Robert N. Shapiro’s Amedisys AMED Stock Holding History

Robert N. Shapiro’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-76	Closed	-$1K	–	998
2013 Q2	$1K	Buy	+76	New	+$871	﹤0.01%	899

Other funds holding AMED

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCA

KKR Credit Advisors San Francisco, California $796M AUM

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Robert N. Shapiro's AMED Position: Q3 2013 in Review

Robert N. Shapiro sold out of Amedisys (AMED) in Q3 2013, closing a stake of 76 shares — an estimated $1K sold.

Robert N. Shapiro first reported a position in AMED in Q2 2013 and held it in 1 quarter. The position peaked at $1K in Q2 2013. 130 funds tracked by Wall St. Rank hold AMED as of Q3 2013.

Robert N. Shapiro reported no remaining Amedisys position as of Q3 2013 after selling out during the quarter.
Robert N. Shapiro sold 76 Amedisys shares in Q3 2013, an estimated $1K.
Robert N. Shapiro first reported a position in Amedisys in Q2 2013 and held it in 1 quarter.
Robert N. Shapiro's Amedisys position peaked at $1K in Q2 2013.
130 funds tracked by Wall St. Rank held Amedisys as of Q3 2013.

Based on Robert N. Shapiro's 13F filing for Q3 2013, filed 19 Nov 2013.